UNICHEMLAB — Unichem Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹33.30bn
- IN₹35.33bn
- IN₹22.02bn
Brief: Unichem Laboratories Gets ANDA Approval From USFDA For Atenolol Tablets
Brief: Unichem Laboratories Gets ANDA Approval For Buspirone Hydrochloride
Brief: Unichem Laboratories Says U.S. FDA's Inspection At Kolhapur Facility Ends Without Any Form 483 Issued
Brief: Unichem Laboratories Gets Receives ANDA Nod From USFDA For Solifenacin Succinate Tablets
Brief: India's Unichem Gets 1 Observation From USFDA Inspection Of Ghaziabad Unit
Brief: Unichem Laboratories Gets USFDA Nod For Chlorthalidone Tablets
Brief: Unichem Laboratories Says Goa Facility Got 4 Observations After USFDA Inspection
Brief: Indian Pharma Firms Sent Notices By Govt Body For Introducing Drugs Without Approval
Brief: Unichem Laboratories March-qtr Profit Surges
Brief: Unichem Laboratories Gets Tentative USFDA ANDA Approval For Cetirizine Hydrochloride Tablets
Brief: Unichem Laboratories Gets Final Approval For Tadalafil Tablets From U.S FDA
Brief: Unichem Laboratories Gets ANDA Approval From USFDA For Allopurinol Tablets
Brief: Unichem Laboratories Gets ANDA Approval For Allopurinol Tablets From USFDA
Brief: Unichem Laboratories Says U.S FDA Conculdes Inspection At Ghaziabad Facility
Brief: Unichem Laboratories Gets Final ANDA Approval For Pramipexole Dihydrochloride Tablets
Brief: Unichem Laboratories Says EU Court Rejects Appeal On Decision Of Breach Of EU Competition Law
Brief: India's Unichem Laboratories Gets Tentative ANDA Approval From U.S FDA For Tadalafil Tablets
Brief: Unichem Laboratories Gets EIR For Post Marketing Adverse Drug Experience Inspection
Brief: Unichem Laboratories Acquires Stake In Optimus Drugs, Optrix Labs